Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia
Clinical trial NCT00237536 · TERMINATED
Trial details
- NCT number
- NCT00237536
- Sponsor
- Threshold Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-01
- Primary completion
- 2006-08-01
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.